Chief executive Tara Comonte said the brand ‘wasn’t as quick to medical weight loss solutions’ as some other firms in the US.

Let’s dig into the relative performance of WeightWatchers (NASDAQ:WW) and its peers as we unravel the now-completed Q4 ...

WeightWatchers Completes Financial Reorganization, Strengthens Leadership, and Expands Program Innovation to Support Women Through Menopause ...

WW International relists on Nasdaq, pivoting to menopause care with GLP-1 drugs and coaching. Click here to read an analysis of WW stock now.

An iconic weight-loss company has emerged from several months of bankruptcy with a revamped business strategy.

WeightWatchers CEO Tara Comonte said such support for members using weight-loss drugs should appeal to health insurers and employers who pay for health benefits as they seek more sustainable ...

CEO Tara Comonte emphasized that the program's comprehensive support would appeal to health insurers and employers seeking to manage costly medications sustainably. The venture into menopause ...

Existing directors Tara Comonte and Julie Bornstein, CEO and Founder of Daydream, will also continue to serve on the new Board.

“This is a pivotal moment for WeightWatchers,” said Tara Comonte, Chief Executive Officer of WeightWatchers. “With renewed financial strength, an expanded leadership team, and the addition ...

“This is a pivotal moment for WeightWatchers,” said Tara Comonte, Chief Executive Officer of WeightWatchers. “With renewed financial strength, an expanded leadership team, and the addition of Dr. Kim ...

Among the appointments were Mike Mason, former president of Eli Lilly's diabetes and obesity business. Existing directors Tara Comonte and Julie Bornstein will continue to serve on the new board.